SOURCE: Medizone International, Inc.

Medizone International, Inc.

August 22, 2011 08:35 ET

AsepticSure™ Launch Produces Sales at FIME

New Generation Disinfection Technology - AsepticSure™ - Generates International Interest and Initial Sales at FIME Medical Purchasing Show in Miami

SAN FRANCISCO, CA--(Marketwire - Aug 22, 2011) - Medizone International, Inc. (OTCBB: MZEI) (OTCQB: MZEI) announced today that the introductory launch and subsequent product sales (at FIME) of its AJIC peer-reviewed disinfection, and hospital infection control system -- AsepticSure™ -- was an unprecedented success.

Medizone's CEO, Edwin Marshall, stated, "Not withstanding the fact that we're delighted to have come away from the Show with two initial orders, one from the US and one from offshore, (with more anticipated), it was an extraordinary three-day event with wide international participation.

Foreign attendees confirmed the unabated spread of hospital-acquired infections in their own countries. The appeal of AsepticSure™ capability was very well received, with one attendee commenting to me, 'this is exactly what I came to the show to look for.'

We now have serious inquires from areas as far reaching as Central and South America, Malaysia, Indonesia, Africa and the Middle East. Based on initial meetings with hospital and government contacts from these regions, it is very clear that they're giving serious consideration to AsepticSure™ -- a technology unparalleled in its ability to sterilize rooms in a green and friendly way to the environment and infrastructure."

Marshall added, "With regard to our initial sales success -- each order is for a first unit to be delivered during Q1 of 2012 at the FIME introductory price of $75,000 with one-year options for three additional units at the standard price of $95,000 each.

If the options are exercised, this will mean that Medizone will have achieved $720,000 in sales during its first three days of offering this technology.

FIME Attendees clearly recognized the unrivalled disinfection capabilities of AsepticSure™ and the contributions our technology will make to the reduction of human suffering and increases in mortality. Just as importantly, they also recognized that AsepticSure™ should save their organizations vast sums of money due to greatly reduced re-admission and legal costs."

Medizone International, Inc. is engaged in final production development of its modular design AsepticSure™ Decontamination Systems. Decontamination to the sterilization standard of > 6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures for building remediation. AsepticSure™ is also proving capable of the eradication of bed bug infestations.

This Press Release contains certain forward looking statements that may involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Contact Information

  • For more information, visit:
    Email: Email Contact

    For press information on Medizone, please contact:
    Jack Eversull
    Investor Relations
    The Eversull Group, Inc.
    T: 001-972-571-1624
    F: 001-214-469-2361
    E: Email Contact